A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE

Clinical trial NCT05171075 · TERMINATED

Trial details

NCT number: NCT05171075
Sponsor: Anthos Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Venous Thromboembolism Deep Venous Thrombosis Pulmonary Embolism

Start date: 2022-09-27
Primary completion: 2026-04-10
Enrollment: 417

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.